Hilltop Holdings Inc. Editas Medicine, Inc. Transaction History

Hilltop Holdings Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $117,144 - $267,211	-2,950 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $79,856 - $248,832	2,950 New	2,950 $207,000
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $434,733 - $567,783	-13,845 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $413,134 - $610,287	13,845 New	13,845 $459,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $183M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

Stay updated on Hilltop Holdings Inc. with notifications on news.